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Calcium and bone homeostasis are intimately related. On the one hand, bone relies on a
sufficient supply of calcium to maintain its structural and mechanical properties and thus
largely depends on calcium absorption in the intestine and calcium reabsorption in the kid-
ney. On the other hand, bone serves as a calcium reserve from which calcium is mobilized
to maintain normal calcium levels in blood. A negative external calcium balance will there-
fore at all times impair skeletal integrity. In addition to the external calcium balance, skeletal
homeostasis also depends on the proper differentiation and functioning of bone cells, which
relies for a large part on intracellular Ca2+ signaling. Members of the transient receptor
potential (TRP) family of ion channels affect skeletal homeostasis by mediating processes
involved in the extracellular as well as intracellular Ca2+ balance, including intestinal calcium
absorption (TRPV6), renal calcium reabsorption (TRPV5), and differentiation of osteoclasts
(TRPV1,TRPV2,TRPV4,TRPV5), chondrocytes (TRPV4), and possibly osteoblasts (TRPV1).
In this review, we will give a brief overview of the systemic calcium homeostasis and the
intracellular Ca2+ signaling in bone cells with special focus on the TRP channels involved
in these processes.
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INTRODUCTION
Calcium is crucial for bone homeostasis, as the skeleton is influ-
enced both by the external Ca2+ balance as well as by the intracellu-
lar Ca2+ signaling in bone cells. First of all, the proper functioning
of the skeleton relies on normal serum calcium levels, but bone
also plays an important role in the maintenance of systemic cal-
cium homeostasis. Indeed, 99% of the bodily calcium is stored in
bone where it contributes to its mechanical and structural proper-
ties. Consequently, bone requires a sufficient supply of calcium to
maintain skeletal integrity. This calcium supply mainly depends
on calcium absorption in the intestine and calcium reabsorption
in the kidney. A failure of one of these processes, as may occur
during insufficient dietary calcium intake, aging, and gastroin-
testinal/renal disorders, therefore greatly increases the risk of a
calcium imbalance and (osteoporotic) bone loss (Bullamore et al.,
1970; Bikle, 2007). These disorders will not only reduce the cal-
cium supply to bone but may also actively reduce the calcium
content in bone as the safeguarding of normal serum Ca2+ levels
will always predominate over the calcium storage in bone. Conse-
quently, bone will contribute significantly to the external calcium
balance by displacing calcium to serum. Although this system is
crucial to maintain normal serum Ca2+ levels and thus to guaran-
tee the optimal functioning of multiple vital processes, the effect
on bone strength is devastating with an increased fracture risk as
a consequence.
Secondly, intracellular Ca2+ is also an important second mes-
senger in bone cells. Intracellular Ca2+ signaling in osteoblasts,
osteoclasts, chondrocytes, and nerve endings has been shown
to regulate numerous functions, including differentiation, signal
transduction, and sensing of mechanical, osmotic, and pain stim-
uli. The fine-tuning of the intracellular Ca2+ levels is thus crucial
for normal bone homeostasis, and abnormalities in the trans-
porters involved in Ca2+ signaling will unambiguously lead to
diseases that also affect bone structure or function (Blair et al.,
2007).
The maintenance of extra- and intracellular Ca2+ homeosta-
sis is thus crucial for bone biology, and depends for a large part
on Ca2+ channels. Several types of Ca2+ channels exist includ-
ing (i) ryanodine receptors (RyR) and inositol-1,4,5-trisphosphate
receptors (IP3R), which mediate the release of Ca2+ from the
endoplasmic reticulum (ER), (ii) store-operated calcium channels
(SOCE), which include ORAI1 and STIM1 and which mediate the
flux of extracellular Ca2+ into the ER via ORAI1 upon intracel-
lular store depletion sensed by STIM1, (iii) voltage-gated Ca2+
channels (VGCC) that allow Ca2+ influx upon cell depolarization,
(iv) stretch-activated Ca2+ channels that mediate Ca2+ influx after
mechanical stimulation, and (v) the transient receptor potential
(TRP) family of cation channels (Robinson et al., 2010). In this
review, we will focus on the involvement of the TRP channels. The
TRP family consists of 28 members which have diverse physiolog-
ical functions. They are subdivided based on their sequence into
six subfamilies, i.e., TRPC (canonical), TRPV (vanilloid), TRPP
(polycystin), TRPM (melastatin), TRPA (ankyrin), and TRPML
(mucolipin). Especially the members of the TRPV family of ion
channels are involved in the extracellular calcium homeostasis and
intracellular Ca2+ signaling in bone cells. The TRPV family con-
sists of six members, which are all membrane proteins composed
of six transmembrane domains that form a cation-permeable
pore region. TRPV1–4 are non-selective cation channels, whereas
TRPV5 and six are highly Ca2+ selective. TRPV channels are
activated by a variety of stimuli. TRPV1 is activated by heat, nox-
ious stimuli, a low pH, and numerous chemicals. TRPV2–4 share
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their activation by heat albeit at different thresholds. Moreover,
TRPV2 and 4 are activated by hypotonicity. TRPV1–4 are therefore
involved in nociception, thermo-, and mechanosensing. TRPV5
and 6 are different from the other TRPV channels in that they are
highly selective to Ca2+ and that they are not activated by heat but
by low intracellular Ca2+ levels. An extensive overview of the struc-
tural and functional aspects of the different members of the TRP
family is beyond the scope of this manuscript, but can be found
in the following articles (Hoenderop et al., 2005; Pedersen et al.,
2005; Nilius et al., 2007). We will focus on the TRP channels that
are involved in the maintenance of the external calcium balance
(TRPV5, TRPV6) and contribute to intracellular Ca2+ signaling
in bone cells (TRPV5, TRPV4, TRPV2, TRPV1; Figure 1). We will
first give a general overview of calcium homeostasis (see Regula-
tion of the External Calcium Balance and its Repercussion on Bone
Homeostasis) followed by a synopsis on intracellular Ca2+ signal-
ing in bone cells (see Intracellular Ca2+ Signaling in Bone Cells).
In each of these two parts we mention the most important Ca2+
channels and briefly describe the TRPV channels involved. Finally,
we will discuss in more detail the functions of each of the specific
TRPV channels in the different tissues and cell types that have a
role in calcium homeostasis and bone biology (see Involvement of
TRP Channels in Bone Biology).
REGULATION OF THE EXTERNAL CALCIUM BALANCE AND
ITS REPERCUSSION ON BONE HOMEOSTASIS
The regulation of systemic calcium homeostasis is directed at
maintaining serum Ca2+ levels within a very narrow range.
Normocalcemia is achieved by a complex endocrine system
that modulates calcium absorption in the intestine, net calcium
secretion in the kidney, and calcium deposition/mobilization from
bone. Briefly, small changes in blood Ca2+ levels trigger the secre-
tion of parathyroid hormone (PTH) from the parathyroid gland.
PTH, in turn, promotes the renal formation of active vitamin
D, 1,25(OH)2D, from its inactive precursor. 1,25(OH)2D action
is key to ensure normocalcemia by regulating processes in the
different calcemic target tissues. Indeed, 1,25(OH)2D enhances
intestinal calcium transport and renal calcium reabsorption.
When these adaptations are insufficient to restore normocalcemia,
1,25(OH)2D triggers a shift of calcium from bone to serum. Fur-
ther activation of this endocrine control system is suppressed by
the normalization of serum Ca2+ levels and by the several negative
feedback loops (Figure 2; Bouillon et al., 2008; Lieben et al., 2011).
Since the diet is the only source of calcium, calcium absorption
in the intestine is a crucial first step in maintaining systemic cal-
cium homeostasis. Intestinal calcium transport consists of two
pathways: a passive, paracellular mechanism that depends on
high dietary calcium levels, and an active pathway that predom-
inates when calcium intake is normal/low and in particular this
mechanism is stimulated by 1,25(OH)2D. Active calcium trans-
port is considered to involve a transcellular mechanism with
calcium entry through an apical Ca2+ channel, followed by intra-
cellular calcium binding to members of the Calbindin family
(Calbindin-D9k) and extrusion to the extracellular milieu by the
Ca2+-ATPase, PMCA1b (Figure 2; Van Cromphaut et al., 2001).
One member of the TRP family, namely TRPV6, has long been
considered to be the rate-limiting step in the active transport of
calcium across the enterocyte by mediating apical Ca2+ transfer
FIGURE 1 | Involvement ofTRP channels in the external calcium balance
and intracellular Ca2+ signaling in bone cells. Bone homeostasis depends
on the external calcium balance which determines whether calcium is stored
in or released from bone, and consequently affects skeletal strength. In
addition, bone homeostasis is also influenced by intracellular Ca2+ signaling in
bone cells, which regulates their differentiation and functioning. Several TRP
channels contribute to both types of processes and more specifically
modulate intestinal calcium transport (TRPV6), renal calcium reabsorption
(TRPV5), and differentiation and functioning of osteoblasts (TRPV1),
osteoclasts (TRPV5, TRPV4, TRPV2, TRPV1), and chondrocytes (TRPV4).
Moreover, TRPV1 expressed in the neurons that innervate bone, plays a
crucial role in the sensing of bone pain.
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FIGURE 2 |The regulation of the external calcium balance. A reduction
in serum Ca2+ levels triggers the release of PTH and the production of
1,25(OH)2D, the active hormone. 1,25(OH)2D in turn modulates several
processes that will ultimately lead to normalization of serum Ca2+ levels: it
will increase intestinal and renal calcium transport, and when these
adaptations are insufficient, 1,25(OH)2D will mobilize calcium from bone
by stimulating osteoclastic bone resorption and by inhibiting bone
mineralization.
(Hoenderop et al., 2005). Recent genetic studies confirm that
TRPV6 contributes to active intestinal calcium transport, but they
also indicate that this channel is not essential for this process (Benn
et al., 2008). A detailed overview of the role of TRPV6 in intestinal
calcium transport and bone homeostasis will be given in Section
“TRPV6.”
Fine-tuning of renal calcium reabsorption also contributes to
the maintenance of normocalcemia. Half of the unbound serum
Ca2+ is intrinsically filtered in the glomerulus, the bulk of this fil-
tered Ca2+ is passively reabsorbed in the nephron. Reabsorption
of the remaining 15% involves an active transport pathway, that
resembles intestinal calcium transport but relies on other media-
tors, i.e., calcium entry via TRPV5, cytosolic binding to Calbindin-
D28k and extrusion by the Na
+/Ca2+ exchanger (NCX1) and
PMCA1b (Figure 2; Bouillon et al., 2008). In contrast to the lim-
ited role of TRPV6 in intestinal calcium transport,genetic evidence
has confirmed that TRPV5 is the essential and rate-limiting step
in renal calcium reabsorption (Hoenderop et al., 2003), which will
be discussed in more detail in Section “TRPV5.”
Calcium stored in bone has two important functions, i.e., pro-
viding mechanical strength and acting as a calcium reserve. The
inherent consequence of this dual role is that it will be difficult,
or even impossible to fulfill these two functions when the external
calcium balance is negative and experimental evidence indicates
that it is the maintenance of normocalcemia that will be secured
by all means. Consequently, a negative calcium balance will lead to
bone loss, which hampers the mechanical function of the skeleton
and may result in an increased fracture risk. We recently showed
that in mice, increased 1,25(OH)2D levels play a crucial role in this
shift of calcium from bone to serum that occurs during a nega-
tive calcium balance. Mechanistically, increased 1,25(OH)2D levels
enhance osteoclastic bone resorption and suppress bone matrix
mineralization by increasing the osteoblastic expression of min-
eralization inhibitors including Osteopontin and pyrophosphates
(Figure 2; Lieben et al., 2012). The preservation of normal calcium
levels in blood and bone is thus closely interconnected, and this
situation also implies that the skeleton not only depends on, but
moreover participates in the external calcium balance. It is there-
fore evident that abnormalities in the external calcium balance due
to loss of TRPV5 (and TRPV6) will also affect bone homeostasis
(see TRPV6 and TRPV5).
INTRACELLULAR Ca2+ SIGNALING IN BONE CELLS
Normal bone homeostasis does not only depend on extracellu-
lar calcium, but also on intracellular Ca2+ signaling cascades that
regulate the differentiation and functioning of multiple bone cells.
In the next section, we will give a concise overview of the mole-
cules involved in intracellular Ca2+ signaling in the bone resorbing
osteoclasts (see Ca2+ Signaling in Osteoclasts), the bone forming
osteoblasts (see Ca2+ Signaling in Osteoblasts), and the chondro-
cytes which contribute to endochondral bone development and
form the articular cartilage (see Ca2+ Signaling in Chondrocytes).
Ca2+ SIGNALING IN OSTEOCLASTS
Recent genetic studies have provided substantial insight in
the molecular mechanisms that are involved in and regulate
osteoclastic Ca2+ signaling and differentiation. In short, bind-
ing of macrophage-colony stimulating factor (M-CSF) to its
receptor on osteoclasts precursors promotes their prolifera-
tion and survival and induces receptor activator of nuclear
factor-κß(RANK) expression (Negishi-Koga and Takayanagi,
2009). Osteoclast differentiation is initiated by the simultaneous
activation of RANK after binding to RANK-ligand (RANKL), and
of the immunoreceptor tyrosine-based activation motif (ITAM)-
associated immunoglobulin-like receptor (IgLR; Takayanagi et al.,
2002; Koga et al., 2004). These signaling pathways induce the acti-
vation of phospholipase Cγ (PLCγ). PLCγ produces IP3, which
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evokes Ca2+ release from the ER via IP3 receptors, that will sub-
sequently lead to typical Ca2+ oscillations (Kuroda et al., 2008).
In vitro findings suggest that TRP channels (TRPV2, see TRPV2;
Kajiya et al., 2010) are likely one of the Ca2+ entry pathways that
contribute to the Ca2+ oscillations (Kajiya et al., 2010; Hwang and
Putney, 2011). With respect to the role of the SOCE, the reported
findings are still limited. In this regard, in vivo inactivation ofOrai1
in mice is reported to impair the formation of multinucleated
osteoclasts and to reduce bone resorption. Consistent herewith,
in vitro inhibition of Orai1 in a murine monocyte/macrophage cell
line (chemical and siRNA) decreased osteoclastogenesis (Hwang
and Putney, 2011; Robinson et al., 2012). Yet conclusive genetic
confirmation based on the generation of osteoclast-specific Orai1
null mice is still lacking and the contribution of ORAI1 to Ca2+
signaling during osteoclast differentiation remains elusive. No
VGCC’s have been detected thus far in osteoclasts, implying that it
is unlikely that they play a role in osteoclast differentiation (Blair
et al., 2007).
The Ca2+ oscillations turn on a number of Ca2+/calmodulin-
activated proteins including calcineurin and calmodulin-
dependent protein kinases (CaMK). Upon activation of the
phosphatase calcineurin, the transcription factor NFATc1 (the
nuclear factor of activated T cells c1) becomes phosphory-
lated, translocates to the nucleus, and increases osteoclast-specific
gene transcription. NFATc1 is the master regulator of osteo-
clast differentiation, evidenced by the complete absence of osteo-
clasts in conditional Nfatc1−/− mice (Aliprantis et al., 2008).
Ca2+/calmodulin signaling also activates the CaMK-mediated
CREB (cAMP response element-binding protein) pathway, which
increases in cooperation with NFATc1, the osteoclast-specific gene
expression. In addition, CREB induces cFOS in the AP (acti-
vator protein) 1 complex, which contributes to the autoampli-
fication of Nfatc1 (Sato et al., 2006). The RANK- and IgLR-
induced Ca2+ oscillations are thus crucial in the initiation of
osteoclastogenesis by promoting NFATc1 and CREB activity
(Figure 3A).
Ca2+ oscillations disappear during osteoclast differentiation
and are replaced by a sustained Ca2+ influx via members of
the TRP family, including TRPV4 (see TRPV4; Masuyama et al.,
2008) and possibly TRPV5 (see TRPV5; Chamoux et al., 2010;
Figure 3B). The Ca2+ oscillations followed by the sustained Ca2+
influx are both needed for NFATc1 activation and proper osteo-
clast differentiation. For more in debt information, we refer to the
review article by Negishi-Koga and Takayanagi (2009).
Ca2+ SIGNALING IN OSTEOBLASTS
In contrast to the osteoclasts, little is known about the
molecular mechanisms mediating osteoblastic Ca2+ signaling
(Blair et al., 2007; Figure 4). Osteoblasts express different fami-
lies of Ca2+ channels, including members of the store-operated
(ORAI1), the stretch-activated, the voltage-gated, and the TRP
family (TRPV6, see TRPV6) of calcium channels. VGCC’s are
important for proper osteoblast functioning and more specifi-
cally for the propagation of calcium waves across neighboring
osteoblasts upon mechanical stimulation. Recent in vitro studies
have demonstrated that the sensitivity and the dynamics of the
calcium waves are even greater in finally differentiated osteoblasts,
i.e., osteocytes, which are believed to be the true mechanosensors
of bone. The changes in the calcium waves with differentiation
are attributed to the presence of a different subset of VGCC’s,
FIGURE 3 | Intracellular Ca2+ signaling in osteoclasts. (A) Early during
osteoclast differentiation, activation of the RANK, and IgLR receptors
induces intracellular Ca2+ oscillations by intracellular Ca2+ release via the
IP3R, and possibly via Ca2+ influx through store-operated Ca2+ channels or
TRP (TRPV2) channels. The Ca2+ oscillations activate Ca2+/
calmodulin-dependent kinases (CaMK, calcineurin) which induce
autoamplification of Nfatc1 and NFATc1-mediated gene transcription. (B)
At later stages, the Ca2+ oscillations diminish and are replaced by a
sustained Ca2+ influx that is predominantly mediated by TRPV4, although
TRPV5 may also play role. Both the Ca2+ oscillations and the sustained
Ca2+ influx are required for the NFATc1-mediated stimulation of osteoclast
differentiation.
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FIGURE 4 | Intracellular Ca2+ signaling in osteoblasts. Osteoblasts
express stretch-activated, voltage-gated (VGCC), store-operated (ORAI1),
and TRP (TRPV6) Ca2+ channels. The response to mechanical stimuli
involves Ca2+ entry via L-type (osteoblasts) and T-type (osteocytes) VGCC’s.
In addition, it is known that osteoblast differentiation requires the activation
of NFAT-mediated gene transcription by Ca2+/calcineurin. The Ca2+ entry
pathways are incompletely characterized but ORAI1 is likely involved.
i.e., L-type VGCC’s in osteoblasts versus the T-type VGCC’s in
osteocytes (Lu et al., 2012).
In addition, Ca2+ signaling is very plausibly involved in
osteoblast differentiation. Chemical inhibition of calcineurin
activity causes a decrease in bone mass and acts by impairing bone
formation (Koga et al., 2005). Similar results are obtained when the
calcineurin Aα isoform is genetically inactivated (Sun et al., 2005).
In contrast, osteoblast-specific inactivation of the calcineurin B
subunit stimulates bone formation (Yeo et al., 2007), indicating
that the role of calcineurin in osteoblast differentiation requires
further investigation. The results regarding the role of NFAT sig-
naling in osteoblasts, on the other hand, are more consistent, i.e.,
genetic inactivation of NFATc1 and NFATc2 in osteoblasts impairs
osteoblastogenesis leading to osteopenia, whereas an opposite phe-
notype is observed when NFATc1 is specifically activated in the
osteoblastic lineage (Koga et al., 2005; Winslow et al., 2006). The
Ca2+ influx pathways that mediate calcineurin/NFAT activation
in osteoblasts, however, are still largely unknown, and require
further investigation. Recent data suggest that the store-operated
Ca2+ channel ORAI1 is involved, as genetic inactivation of Orai1
impairs osteoblast differentiation and bone formation in vitro and
in vivo (Robinson et al., 2012).
Ca2+ SIGNALING IN CHONDROCYTES
Chondrocytes express several Ca2+ channels, including VGCC’s,
stretch-activated Ca2+ channels, and TRP channels (TRPV4),
which are involved in chondrocyte differentiation and osmosens-
ing. First of all, calcium influx via the L-type VGCC’s and
TRPV4 is required to activate a Ca2+/calmodulin signaling cas-
cade that promotes chondrocyte differentiation. Consequently,
suppression of L-type VGCC’s (Mancilla et al., 2007), TRPV4
(Muramatsu et al., 2007), and Ca2+/calmodulin (Taschner
FIGURE 5 | Intracellular Ca2+ signaling in chondrocytes. (A)
Chondrocyte differentiation involves Ca2+ entry via L-type VGCC’s and
TRPV4, that leads to the Ca2+/calmodulin-mediated induction of SOX9. (B)
Hypo-osmotic stimuli activate TRPV4, and most likely the TRPV4 channels
present on the primary cilium, leading to the increase in intracellular Ca2+
levels which is required for the volumetric changes and chondroprotection.
et al., 2008) signaling hampers chondrocyte differentiation in
rat metatarsal cultures, chondrogenic cell lines, and chicken
chondrocytes respectively. Thus, Ca2+ influx via VGCC’s and
TRPV4 (see TRPV4) is required for proper chondrogenesis
(Figure 5A).
Secondly, Ca2+ signaling is involved in the osmosensing prop-
erties of chondrocytes, which are essential to maintain joint health.
The articular chondrocytes in particular are exposed to large vari-
ations in their osmotic environment due to changes in the water
content of the cartilage matrix upon loading and reloading of
the joint. Chondrocytes respond directly to this osmotic stress by
promoting Ca2+ influx and increasing intracellular Ca2+ levels
which leads to volumetric changes. Abnormalities in this system
result in or fasten the progression of rheumatoid arthritis. Recent
studies have provided compelling evidence that TRPV4 is crit-
ically involved in the sensing of hypo-osmotic stimuli (Guilak
et al., 2010), which we will further discuss in Section “TRPV4”
(Figure 5B).
INVOLVEMENT OF TRP CHANNELS IN BONE BIOLOGY
Transient receptor potential channels may affect skeletal home-
ostasis not only by regulating the external calcium balance but
also by directly altering Ca2+ signaling in bone cells. The TRP
channels that are known to be involved in one of these processes
will be discussed in more detail (Figure 1).
TRPV6
Active intestinal calcium transport is required when dietary
calcium intake is normal/low. This pathway is stimulated by
1,25(OH)2D and involves calcium entry mediated in part by
TRPV6, intracellular calcium binding to Calbindin-D9k, and baso-
lateral extrusion of calcium via PMCA1b (see Regulation of
the External Calcium Balance and its Repercussion on Bone
Homeostasis; Figure 2). TRPV6 has for long been considered
www.frontiersin.org August 2012 | Volume 3 | Article 99 | 5
Lieben and Carmeliet TRP’s in bone
to be the rate-limiting step in active intestinal calcium absorp-
tion, based on the finding that intestinal TRPV6 levels are
altered in parallel with 1,25(OH)2D activity and inversely with
dietary calcium intake. Indeed, Trpv6 mRNA levels are upreg-
ulated by 1,25(OH)2D treatment and a low dietary calcium
intake, whereas Trpv6 expression is reduced in Vdr null mice
or in response to a high calcium intake (Van Cromphaut et al.,
2001).
Genetic studies confirm that TRPV6 is involved in intestinal
calcium transport, but they also show that TRPV6 is not essen-
tial for this pathway. Indeed, active intestinal calcium transport
is only minimally affected in Trpv6 and Trpv6/Calbindin-D9k
double null mice when mice are fed a diet containing a nor-
mal level of calcium (Bianco et al., 2007; Benn et al., 2008).
In addition, 1,25(OH)2D treatment results in a similar increase
in intestinal calcium transport in Trpv6−/−, Trpv6/Calbindin-
D9k
−/−, and wild-type mice (Benn et al., 2008; Kutuzova et al.,
2008). Dietary calcium deprivation also stimulants intestinal cal-
cium transport in all genotypes, yet the increase was less pro-
found in the Trpv6−/− and Trpv6/Calbindin-D9k−/− mice (Bianco
et al., 2007; Benn et al., 2008). Altogether, these results indi-
cate that TRPV6 is redundant for intestinal calcium absorp-
tion during normal calcium intake, but that this Ca2+ channel
does contribute to this process when dietary calcium levels are
low.
Thus, TRPV6 contributes only minimally to intestinal cal-
cium transport during normal calcium intake. Consequently,
Trpv6−/− mice have normal serum calcium levels (Bianco et al.,
2007; Benn et al., 2008) and display no abnormalities in bone
homeostasis, evidenced by normal bone mass and remodeling
parameters. Also the growth plate morphology is not affected
which accords with normal serum calcium and phosphate levels
(Lieben et al., 2010). Similarly, knock-in mice with a replace-
ment of one amino acid of the Trpv6 gene (Trpv6D541A/D541A
mice) that impairs the Ca2+ permeability of TRPV6, do not dis-
play changes in bone mass and morphology, yet their bone size is
slightly reduced (van der Eerden et al., 2012). In contrast to the
redundancy of TRPV6 during normal calcium intake, TRPV6 is
required for optimal intestinal calcium absorption when dietary
calcium is limited. Accordingly, Trpv6 null mice on a low cal-
cium diet could maintain normal serum calcium levels, yet their
bone matrix mineralization is more profoundly reduced com-
pared to wild-type mice (Lieben et al., 2010). Thus, TRPV6 is
essential to ensure adequate intestinal calcium absorption dur-
ing dietary calcium deprivation, and hereby prevents an excessive
decrease in bone mineralization. These findings also underscore
the essential role of adequate dietary calcium absorption for
skeletal health.
The absence of bone abnormalities during normal calcium
intake indicates that TRPV6 only indirectly affects the skele-
ton via its involvement in intestinal calcium transport. Yet,
TRPV6 is expressed in osteoblasts and osteoclasts, albeit at
very low levels (1% of intestinal levels; Lieben et al., 2010;
Little et al., 2011), and may thus in theory directly regulate
their differentiation or functioning. Recent studies have how-
ever convincingly demonstrated that TRPV6 is not involved in
osteoblastic Ca2+ uptake (Little et al., 2011) nor mineralization
(van der Eerden et al., 2012). Altogether, these results con-
firm that TRPV6 lacks a direct role in bone metabolism
(Figure 4).
In conclusion, TRPV6 affects skeletal metabolism by promot-
ing intestinal calcium transport, and is especially required during
dietary calcium deprivation.
TRPV5
TRPV5 is critically involved in renal calcium reabsorption (see
Regulation of the External Calcium Balance and its Repercussion
on Bone Homeostasis; Figure 2). Indeed, inactivation of Trpv5
results in a decrease in renal calcium reabsorption, leading to severe
urinary calcium loss. Normal serum calcium levels are maintained
via a compensatory, 1,25(OH)2D-mediated increase in intestinal
calcium absorption. Furthermore, cortical bone mass is reduced
in Trpv5−/− mice, which is associated with an increase in osteo-
clast number, though bone resorption parameters are reduced
(Hoenderop et al., 2003). These results convincingly demonstrate
that TRPV5 is important for systemic calcium homeostasis by
fine-tuning renal calcium reabsorption.
The skeletal defect in Trpv5−/− mice may be due to the abnor-
mal external calcium balance and/or to direct changes in osteoclas-
tic Ca2+ signaling. Of note, TRPV5 is not expressed in osteoblasts.
In osteoclasts, on the other hand, TRPV5 is found at the ruf-
fled border, where it likely contributes to bone resorption. van
der Eerden et al. reported that the in vitro differentiation of
hematopoietic precursors isolated from Trpv5 null mice leads to
more and larger osteoclasts, but with severely impaired resorptive
capacity. The resorption deficit is attributed to the lack of TRPV5
activity, whereas the enhanced osteoclastogenesis is explained by
an increased priming of the osteoclast precursors by the high
1,25(OH)2D levels in Trpv5−/− null. These finding are in agree-
ment with the increased osteoclast number but reduced bone
resorption observed in Trpv5 null mice, yet it is still unclear how
these findings explain and correlate with the reduced bone mass
in vivo (van der Eerden et al., 2005). Chamoux et al. reported
that TRPV5 mediates the RANKL-induced sustained Ca2+ influx
in more differentiated human osteoclasts in vitro, and surpris-
ingly, they observed that inhibition of Trpv5 leads to increased
resorption pit formation in vitro. Unfortunately, data concerning
the effect of Trpv5 inactivation on osteoclast differentiation itself
is lacking in this study (Chamoux et al., 2010). Thus, TRPV5 is
present at the ruffled border of resorbing osteoclasts, but its exact
role in osteoclastic Ca2+ signaling, osteoclastogenesis, and bone
resorption is still unclear (Figure 3).
In conclusion, TRPV5 mediates calcium reabsorption in the
kidney, and is hereby important for the maintenance of systemic
calcium and bone homeostasis. In addition, TRPV5 is expressed
in osteoclasts and may directly regulate osteoclast differentiation
and/or functioning.
TRPV4
That TRPV4 has a profound role in bone homeostasis is well
demonstrated by the skeletal defects resulting from TRPV4 muta-
tions in humans. Activating missense mutations in TRPV4 lead to a
wide spectrum of autosomal-dominant skeletal dysplasias ranging
from mild to lethal forms, and are characterized by cartilage and
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mineralization defects (Rock et al., 2008; Krakow et al., 2009). This
finding, together with the observation that TRPV4 is expressed in
chondrocytes, osteoclasts, and osteoblasts, suggests that TRPV4
directly controls the functioning of skeletal cells.
We showed that TRPV4 is present on the basolateral mem-
brane of osteoclasts and is required for osteoclast differentiation
by regulating intracellular Ca2+ signaling (see Ca2+ Signaling in
Osteoclasts; Figure 3). More specifically, TRPV4 mediates the
sustained Ca2+ influx that occurs in the late stages of osteo-
clast differentiation, when the Ca2+ oscillations are no longer
present (Masuyama et al., 2008; Negishi-Koga and Takayanagi,
2009). This TRPV4-mediated Ca2+ influx secures intracellular
Ca2+ concentrations, ensures NFATc1-regulated gene transcrip-
tion, and regulates the terminal differentiation and activity of
the osteoclasts. Indeed, intracellular Ca2+ levels, NFATc1 activ-
ity, osteoclast differentiation and resorptive capacity are reduced
in Trpv4−/− osteoclasts. No difference in the percentage of oscil-
lating cells, the frequency or the amplitude of the Ca2+ oscillations
is observed between Trpv4−/− and Trpv4+/+ osteoclasts, implying
that TRPV4 is not involved in the generation or the maintenance
of the Ca2+ oscillations. In agreement with the in vitro find-
ings, bone mass is increased in adult Trpv4−/− mice, and this is
accompanied by a reduction in osteoclast abundance and bone
resorption. Of note, TRPV4 inactivity does not affect systemic cal-
cium homeostasis nor bone formation (Masuyama et al., 2008).
Thus, Ca2+ oscillations and sustained Ca2+ influx via TRPV4
are sequentially required for osteoclast differentiation. In agree-
ment with these finding,Trpv4−/− mice are also protected against
unloading-induced bone loss (Mizoguchi et al., 2008). In addition,
a recent study shows that activation of TRPV4 specifically in osteo-
clasts increased osteoclast differentiation, which leads to bone loss.
The authors also demonstrate that TRPV4 not only affects osteo-
clast differentiation via the Ca2+-mediated activation of NFATc1,
but that TRPV4 also influences osteoclast migration and fusion
via Ca2+/calmodulin-mediated effects on myosin IIa (Masuyama
et al., 2012). Thus, TRPV4 is critically involved in osteoclast differ-
entiation and migration, by mediating the sustained Ca2+ influx
in more differentiated osteoclasts.
TRPV4 is also expressed in chondrocytes, where it modulates
differentiation and osmotically induced Ca2+ signaling (see Ca2+
Signaling in Chondrocytes; Figure 5). First of all, TRPV4 acti-
vation is found to induce SOX9 expression, a master regulator
of chondrogenesis (Bi et al., 1999) through a Ca2+/calmodulin
pathway, and by doing so, TRPV4 potentiates chondrogenic differ-
entiation in vitro (Muramatsu et al., 2007). This finding indicates
that TRPV4 is positively involved in chondrogenesis. Secondly,
TRPV4 mediates the chondrocyte response to hypo-osmotic stress,
which is required to maintain joint health. Indeed, suppression
of TRPV4 activity abolishes the osmotic sensitivity of chon-
drocytes, impairs the increase in intracellular Ca2+ levels, and
suppresses the volume decrease (Phan et al., 2009). Chemical dis-
ruption of the primary cilium also eliminates the Ca2+ signaling
in response to an activator of TRPV channels and hypo-osmotic
stimuli (Phan et al., 2009). This finding suggests that an intact cil-
ium is required for TRPV4-mediated Ca2+ signaling. Remarkably,
TRPV4 is distributed all over the plasma membrane, and was thus
not strictly localized to the cilium (Phan et al., 2009). Consistent
with these in vitro findings, Trpv4−/− mice develop early and
severe osteoarthritis with progressive calcification of the joint tis-
sue (Clark et al., 2010). Altogether, TRPV4 has a chondroprotective
role by mediating the response to hypo-osmotic stimuli.
Thus, TRPV4 directly regulates differentiation and functioning
of osteoclasts and chondrocytes by mediating intracellular Ca2+
influx and signaling.
TRPV2
TRPV2 is expressed in osteoclasts and is likely involved in the
Ca2+-permeable pathway that mediates osteoclastic Ca2+ oscil-
lations (see Ca2+ Signaling in Osteoclasts; Figure 3). In fact,
inhibition of TRPV2 hampers the RANKL-induced Ca2+ oscil-
lations, NFATc1 activation, and osteoclastogenesis in vitro (Kajiya
et al., 2010), yet conclusive in vivo evidence is currently lacking.
TRPV1
TRPV1 is expressed in osteoblasts and osteoclasts and promotes
the differentiation of both cell types. Indeed, pharmacological
blockage of TRPV1 inhibits in vitro osteoclast and osteoblast
differentiation. Moreover, in vivo suppression of TRPV1 activity
protects mice against ovariectomy-induced bone loss by reducing
the increase in bone resorption and formation (Idris et al., 2010).
Thus, TRPV1 may directly affect osteogenic cell differentiation.
More importantly, TRPV1 is present in peripheral neurons that
innervate bone, and TRPV1-mediated Ca2+ signaling in these
neurons has an important function in the pain sensation that
often accompanies bone metastases or inflammatory osteoarthri-
tis. Indeed, growing tumor cells trigger osteoclasts to resorb bone
excessively and this process induces an acid microenvironment
due to the secretion of H+ by the osteoclasts. This acidity activates
TRPV1 and other acid-sensing ion channels on the nociceptors
that innervate bone. The associated Ca2+ influx triggers a series of
events that are associated with pain (Nakanishi et al., 2010). Con-
sequently, suppression of the excessive bone resorption or TRPV1
activity significantly lowers bone pain in mice (Nagae et al., 2006,
2007; Tong et al., 2010).
CONCLUSION
Bone homeostasis depends on the external calcium balance as
well as on intracellular Ca2+ signaling that regulates bone cell
functioning and differentiation. A number of TRP channels are
critically involved in the regulation of these processes, includ-
ing intestinal calcium absorption (TRPV6), renal calcium reab-
sorption (TRPV5), osteoclastogenesis (TRPV4, TRPV5, TRPV2,
TRPV1), osteoblastogenesis (TRPV1), chondrocyte differentia-
tion/functioning (TRPV4), and bone pain sensation (TRPV1).
The combination of in vitro and in vivo studies have provided
tremendous insight in the role of TRP channels in calcium and
bone homeostasis, but some aspects still require further investi-
gation. First of all, the finding that TRPV6 is not essential for
active intestinal transport, urges the search for new Ca2+ chan-
nels or alternative mechanisms that mediate calcium transport
in the intestine. Secondly, the mechanisms that modulate Ca2+
oscillations during the early of osteoclastogenesis are still largely
unknown, yet of interest given that this pathway is crucial for the
autoamplification of NFATc1 and thus osteoclast differentiation.
www.frontiersin.org August 2012 | Volume 3 | Article 99 | 7
Lieben and Carmeliet TRP’s in bone
Thirdly, despite the fact that NFAT is important for osteoblast
differentiation, the Ca2+ entry mechanisms that evoke NFAT acti-
vation are largely unexplored. In a next step, in vitro studies
combined with the generation of mouse models that target the dif-
ferent TRP channels in a cell-specific manner, will provide more
insight in their role in calcium and bone homeostasis. A better
understanding is required to define whether the different TRP
channels may serve as therapeutic targets in conditions of bone
loss. Indeed one may speculate to use TRPV5 and TRPV6 agonists
to maximize the calcium availability for bone, TRPV4 modulators
to suppress osteoclast differentiation or to treat genetic dysfunc-
tioning of TRPV4, etc. Thorough insight may also help to avoid
possible side-effects that may occur when inhibiting/stimulating
their function since TRPV channels are structurally related and
thus require the development of highly specific modulators. In
addition, the different TRPV channels have numerous important
physiological functions in different tissues, a condition that may
hinder its general application. To date, only TRPV1 modulators
are used in the clinic as part of analgesic therapy (Moran et al.,
2011).
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